Pharmacological profiling of Orthochirus scrobiculosus toxin 1 analogs with a trimmed N-terminal domain.

Abstract : OSK1, a toxin from the venom of the Asian scorpion Orthochirus scrobiculosus, is a 38-residue peptide cross-linked by three disulfide bridges. A structural analog of OSK1, [Lys(16),Asp(20)]-OSK1, was found previously to be one of the most potent blockers of the voltage-gated K(+) channel Kv1.3 hitherto characterized. Here, we demonstrate that progressive trimming of the N-terminal domain of [Lys(16),Asp(20)]-OSK1 results in marked changes in its pharmacological profile, in terms of both K(+) channel affinity and selectivity. Whereas the affinity to Kv1.1 and Kv1.3 did not change significantly, the affinity to Kv1.2 and K(Ca)3.1 was drastically reduced with the truncations. It is surprising that a striking gain in potency was observed for Kv3.2. In contrast, a truncation of the C-terminal domain, expected to partially disrupt the toxin beta-sheet structure, resulted in a significant decrease or a complete loss of activity on all channel types tested. These data highlight the value of structure-function studies on the extended N-terminal domain of [Lys(16),Asp(20)]-OSK1 to identify new analogs with unique pharmacological properties.
Type de document :
Article dans une revue
Molecular Pharmacology, American Society for Pharmacology and Experimental Therapeutics, 2006, 69 (1), pp.354-62. 〈10.1124/mol.105.017210〉
Liste complète des métadonnées

http://www.hal.inserm.fr/inserm-00381703
Contributeur : Marco Canepari <>
Soumis le : mercredi 6 mai 2009 - 14:14:13
Dernière modification le : mercredi 14 février 2018 - 18:16:02

Lien texte intégral

Identifiants

Collections

Citation

Stéphanie Mouhat, Georgeta Teodorescu, Daniel Homerick, Violeta Visan, Heike Wulff, et al.. Pharmacological profiling of Orthochirus scrobiculosus toxin 1 analogs with a trimmed N-terminal domain.. Molecular Pharmacology, American Society for Pharmacology and Experimental Therapeutics, 2006, 69 (1), pp.354-62. 〈10.1124/mol.105.017210〉. 〈inserm-00381703〉

Partager

Métriques

Consultations de la notice

165